FDA Medical devices recall ·

Apo B Reagent recall

Recall number
Z-1815-2025
Date
(initiated April 23, 2025)
Company / brand
Beckman Coulter Ireland, Inc.
Lismeehan, O'Callaghan'S Mills, N/A, Ireland
Category
Medical devices › Class III
Classification
Class III
Status
Ongoing
Units affected
2747 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Apo B Reagent, REF: OSR6143

Why was it recalled?

The product Value Assignment Sheet (VAS) is used in calibration of the device. An erroneous value was included in the VAS which has the potential to generate an incorrect APO B patient result which could exceed the total allowable error for the APO B assay (11.6%). The error results in results with a positive bias up to 42%. However, based on the mitigating factors the risk to health is considered to be negligible or limited.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot # 2631/UDI: 15099590010409

Distribution

Worldwide - US Nationwide distribution in the states of AZ, CA, CO, FL, GA, IL, IN, MD, MI, NJ, NY, OH, OK, OR, PA, TX, VA, WA, WV and the countries of Argentina, Australia, Belarus, Belgium, Bulgaria, Canada, China, Czechia, Egypt, Estonia, France, Germany, Ghana, Greece, Hong Kong, India, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Russian Federation, Saudi Arabia, Slovakia, Spain, Switzerland, Taiwan, Province of China, United Kingdom of Great Britain and Northern Ireland, United States of America, Viet Nam.

States: Arizona California Colorado Florida Georgia Illinois Indiana Maryland Michigan New Jersey New York Ohio Oklahoma Oregon Pennsylvania Texas Virginia Washington West Virginia

What does Class III mean?

Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).

Source: FDA (medical devices), recall Z-1815-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.